A relação entre patentes farmacêuticas e programas públicos de saúde
This paper discusses how the patent was set up mainly relating to the pharmaceutical sector since 1995 with the implementation of the TRIPS agreement. The issue presents the flexibilities that must be used in benefit of public health, which was reinforced by the Doha Declaration in 2001. Some more r...
Main Author: | José Flávio de Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
2012-08-01
|
Series: | Cadernos de Campo |
Subjects: | |
Online Access: | https://periodicos.fclar.unesp.br/cadernos/article/view/5169/4234 |
Similar Items
-
A relação entre patentes farmacêuticas e programas públicos de saúde
by: José Flávio de Castro
Published: (2011-01-01) -
COMPULSORY LICENSING MECHANISM UNDER INTERNATIONAL AND NATIONAL LAW
by: Aslan H Abashidze, et al.
Published: (2019-12-01) -
Patents in the pharmaceutical industry
by: Jovanović Slobodanka
Published: (2003-01-01) -
The WTO and the Covid‐19 “Vaccine Apartheid”: Big Pharma and the Minefield of Patents
by: Stéphane Paquin, et al.
Published: (2023-03-01) -
Letters to the MJM
by: Bishnu Rath Giri, et al.
Published: (2020-12-01)